Continue minoxidil application and add AHK-Cu injections on the same schedule
The combination had even more dramatic effects
MedSole RCM's claim submissions process includes a pre-submission diagnosis pointer audit that catches 837P loop mismatches before they generate CO-16 denials
Second-line treatments, known as device-aided therapies (DATs), have been developed for LDRCs, such as continuous subcutaneous apomorphine infusion (CSAI), continuous subcutaneous foslevodopafoscarbidopa, infusion of levodopacarbidopa intestinal gel (LCIG entacapone) and subthalamic deep brain stimulation
It is not approved for human or animal administration and must not be used in food, dietary supplements, pharmaceuticals, cosmetics, or any consumer applications